My research program interfaces immuno-oncology with AI/statistical approaches to in silico screen gene targets and drugs for precision therapies. It devises "bipotent" immunotherapies that kill cancer by multiple mechanisms by harnessing large-scale datasets through novel approaches.
Swiss Federale Scholar (EFPL)
Ecole Polytechnic Federale De Lausanne
EDIC Swiss Fellowship
Ecole polytechnic federale de lausanne
Dean Fellowship
University of Maryland
GPP fellowship
National Human Genome Research Institute
German Govt fellowship
Max Planck Institute
National Inst. Minority Health and Health Disparity Fellowship
National Institute of Minority Health and Health Disparity
Michelson Prize, Human Vaccine Project
Michelson Foundation
K99/R00 Pathway to Independence Award 2020-2025
National Cancer Institute
40 promising young scientists in Cancer Immunology
Arthur L. Irving Family Foundation Cancer Immunology